BioSpace News Archive

It’s the first advancement in surgical hardware technology in three decades. Dallas based Medcillary has been selected as part of a worldwide team of distributors bringing it to market.

Summit Healthcare REIT, Inc’s (“Summit”) Board of Directors announced that Kent Eikanas has been promoted to the position of Chief Executive Officer, effective immediately

MiLaboratories LLC, a technology leader in T-cell receptor (TCR) and B-cell receptor (BCR) profiling and MIODx, a well-known immunosequencing specialist, announced today a collaboration agreement to expand the provision of services and product development.

Novo Nordisk to award promising start-ups free space at Boston’s premier, biotech-capable shared lab facility

Chronic pain, inflammation and depression are major components of many conditions such as CRPS (RSD), Fibromyalgia, Treatment-Resistant Depression, PTSD and Chronic Lyme Disease Syndrome.

CVS Health Corporation announced the applicable Reference Yields and Total Consideration to be paid in connection with the previously announced cash tender offers for any and all of its 3.125% Senior Notes due 2020 and any and all of its 4.125% Senior Notes due 2021, the 4.125% Senior Notes due 2021 issued by its wholly-owned subsidiary, Aetna Inc. and the 5.450% Senior Notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna.

Today, the Food and Drug Administration (FDA) announced its approval of pretomanid, a new drug developed to treat Extensively Drug-Resistant Tuberculosis (XDR-TB) and treatment intolerant/non-responsive Multidrug-Resistant (MDR) TB

The Privately-Owned ER Alternative is Staffed by ER Doctors and Offers Patients More Medical Services Than Most Urgent Care Centers.

As recommended by the National Council on Disability, all U.S. dental schools must now revamp their curricula and training programs to be inclusive of patients with intellectual and developmental disabilities.

Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement (RCA) focused on the use of real-world evidence (RWE) to support regulatory decision-making.